Corbus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.

CEO

Yuval Cohen

CEOYuval Cohen

Employees

Employees19

Headquarters

Norwood, Massachusetts

HeadquartersNorwood, Massachusetts

Founded

2009

Founded2009

Employees

Employees19

CRBP Key Statistics

Market cap

408.76M

Market cap408.76M

Price-Earnings ratio

-3.74

Price-Earnings ratio-3.74

Dividend yield

—

Dividend yield—

Average volume

180.76K

Average volume180.76K

High today

$39.24

High today$39.24

Low today

$37.52

Low today$37.52

Open price

$39.06

Open price$39.06

Volume

108.03K

Volume108.03K

52 Week high

$49.87

52 Week high$49.87

52 Week low

$3.03

52 Week low$3.03

CRBP News

Yahoo Finance 6d

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum - Yahoo Finance

Corbus Pharmaceuticals Holdings, Inc. NORWOOD, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “C...